logo-loader
TSX-V:TLT OTCQB:TLTFF

Theralase Technologies Inc

Receive alerts
Market:
TSX-V
Price
0.17 CAD
Day Change
-8.33%
Market Cap:
$38.8 m
52 weeks high
0.31
52 weeks low
0.16

In brief

Theralase Technologies Inc is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations intended to safely and effectively destroy various cancers.

Insight Widest with the analysis, Proactive gives perspectives that others don't.